Management of a Central Line with Clot Around the Tip

1. Understanding the Type of Clot

• Grainger & Allison's Diagnostic Radiology

• Roberts and Hedges' Clinical Procedures in Emergency Medicine

2. Management by Scenario

A. Intraluminal Occlusion (Catheter Won't Aspirate)

1. Aspiration attempt - First, attempt to aspirate the clot.
2. Thrombolytics into the lumen - Instill recombinant tPA (alteplase) directly into the catheter lumen. Standard dosing: 2 mg/2 mL per lumen, dwell for 30-120 minutes, then aspirate.
3. Catheter exchange - If thrombolytics fail, exchange over a guidewire (Seldinger technique).

• Grainger & Allison's Diagnostic Radiology

B. Fibrin Sheath

1. Thrombolytic therapy - intraluminal tPA as above; may temporarily restore function.
2. Catheter exchange over a stiff hydrophilic wire through a long peel-away sheath (preserves venous access site).
3. Balloon venoplasty - to disrupt the fibrin sheath before inserting the new catheter through the peel-away sheath.
4. Fibrin sheath stripping - a snare introduced from a femoral approach can mechanically strip the sheath. Note: both venoplasty and stripping risk fibrin fragment embolization into the pulmonary circulation.
5. A Cochrane review found catheter exchange and mechanical fibrin sheath disruption are probably better for long-term catheter survival than thrombolytic therapy alone.

• Grainger & Allison's Diagnostic Radiology

C. Significant Vessel/Peritip Thrombosis (e.g., DVT, SVC Thrombosis)

1. Anticoagulation - the primary treatment. Options include:
   • LMWH - preferred by most clinicians per survey data (50% of intensivists/hematologists chose LMWH for symptomatic CRT). Duration: typically 3-6 months (in adults); 1-3 months in children under 2 years with catheter-related thrombosis.
   • DOACs - comparable efficacy and bleeding rates to LMWH/VKA; increasingly used.
   • VKA (warfarin) is an alternative.
   • The 2026 systematic review and meta-analysis (Oomen et al., PMID 41319857) found VTE recurrence rates are similar between DOACs and LMWH/VKA. Rates are significantly higher in patients with cancer (14.1 vs 2.0 per 100 patient-years).
2. Catheter removal - consider if the catheter is no longer needed or if it is the source of ongoing thrombus. Removal + anticoagulation may be sufficient to relieve symptoms.
3. Catheter-directed thrombolysis (CDT) - for large or hemodynamically significant thrombosis. Used in combination with anticoagulation.
4. Surgical or endovascular thrombectomy - reserved for cases where anticoagulation and thrombolysis fail, or when new complications arise (e.g., SVC syndrome, right atrial thrombus with hemodynamic compromise).

• Sabiston Textbook of Surgery; Fuster and Hurst's The Heart

D. Catheter-Related Right Atrial Thrombus (Special Case)

• Overall mortality 18.1%
• Recommended approach: catheter replacement + anticoagulation combined with thrombolysis
• Thrombectomy when other methods fail or complications arise
• Thrombolysis alone has a low success rate

3. Duration of Anticoagulation

• The Harriet Lane Handbook, 23rd ed.; Oomen et al. 2026

4. Prevention

• Keep catheter tip in the SVC (not lower in right atrium) - tips positioned low in the right atrium have higher thrombus formation risk.
• Heparin-bonded catheters reduce catheter-related thrombosis.
• Heparin or citrate catheter locks after each use.
• Minimize dwell time; review daily necessity.
• Miller's Anesthesia, 10th ed.; Roberts and Hedges'

Key Recent Evidence

• Oomen et al. 2026 (PMID 41319857) - systematic review + meta-analysis of 34 observational studies: LMWH/VKA vs. DOACs show similar VTE recurrence and bleeding rates; well-designed RCTs are still lacking.
• Chen et al. 2024 (PMID 39563254) - for right atrial thrombus in hemodialysis: combination catheter replacement + anticoagulation + thrombolysis is preferred; thrombectomy is a rescue option.